The Pharmacy Times® Weight Management Resource Center is a comprehensive resource for clinical news and expert insights on issues related to chronic obesity and the associated health issues.
April 18th 2024
Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Once-Weekly Insulin Analogue Demonstrates Promising Results for Those With Type 2 Diabetes
July 25th 2023Patients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.
Read More